Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
Pan, Chen, Zhang et al. investigated the anti-cancer efficacy of CA170, a small molecule agonist of VISTA, on mouse lung tumorigenesis. When combined with a MHCII-directed KRAS peptide vaccine, the authors reported that CA170 suppressed lung tumor development by increasing CD8+ T cell and decreasing...
Guardado en:
Autores principales: | Jing Pan, Yao Chen, Qi Zhang, Achia Khatun, Katie Palen, Gang Xin, Li Wang, Chuanjia Yang, Bryon D. Johnson, Charles R. Myers, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Yian Wang, Weiguo Cui, Ming You |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25463f045f454089abc25f6e7b64cc74 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy
por: Pottayil G. Sasikumar, et al.
Publicado: (2021) -
Explosive eruption, flank collapse and megatsunami at Tenerife ca. 170 ka
por: Raphaël Paris, et al.
Publicado: (2017) -
Acta Nº170
por: Banco Central de Chile
Publicado: (2019) -
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
por: Na Li, et al.
Publicado: (2017) -
The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis
por: Amina Ghouzlani, et al.
Publicado: (2021)